植物中转基因的整合机制

转基因在植物基因组中的整合分两步:在整合前阶段,转化的完整质粒及转基因片段经重组连接形成转基因串联子(transgenearray),其中不含任何植物基因组序列,连接反应由植物细胞本身的酶催化,仅依赖于游离的DNA末端,CaMV35S启动子和TDNA边界序列中的特定序列可能充当重组热点;在整合阶段,转基因DNA通过微同源介导的异常重组整合到植物基因组中,最初的整合位点作为整合热点,引导随后的转基因分子在该位点附近整合,不同转基因位点可被1～10kb植物DNA隔开,形成转基因簇(transgenecluster)。     

内含子的位置不影响转基因的表达

内含子在转基因动物的基因表达中具有重要作用,以乳清酸蛋白（ＷＡＰ）基因５′区为调控序列,人基因组Ｇ－ＣＳＦ基因为目的片段,将ＷＡＰ基因第一内含子插入Ｇ－ＣＳＦ基因５′端,构建成转基因动物乳腺表达载体。将其直接注射到小鼠乳腺,在泌乳期表达出人Ｇ－ＣＳＦ。表明内含子在５′端的位置不影响转基因的表达,同时也表明内含子对表达有一定的作用。     

桑树对花叶病抗性遗传规律的研究

用7个母本、5个父本品种,按NCII杂交设计,进行桑树对花叶病抗性的遗传分析。首次证明：桑树对花叶病的抗性具有数量遗传特点,符合加性－显性模型,主要受加性基因控制,广义遗传力和狭义遗传力中等,一般配合力显示绝对优势,具有超显性现象。母本品种含有比父本品种更多的显性基因。 Abstract　Seven maternal and five paternal varieties of mulberry were used in inheritance experiment by NCII mating design. Genetic study of mulberry resistance to the mosaic disease was carried out. The results showed for the first time that mulberry resistance to the mosaic disease showed charateristics of quantitative inheritance, it tallied with the model of additive-dominance, it was mainly controlled by additive genes. Broad heritability and narrow heritality were moderate. The general combining ability showed absolute superiority. The resistance showed overdominant phenomenon. The maternal variety had more the dominance gene than paternal.     

转基因在玉米中的遗传分离与整合特性的研究

用ＰＣＲ和ＤＮＡ分子杂交方法研究了转基因Ｂｔ在３种不同方法获得的８个转化体后代中的遗传分离、整合性质及其稳定性,结果表明：（１）转基因在大多数转化体后中呈简单的孟德尔遗传;在Ｒ１至Ｒ２代,部分家系中转化体比例偏低,有的发生转基因丢失,但到Ｒ３代以后均趋于正常的孟德尔遗传方式,在群体中固定下来;（２）转基因在不同转化体中的整合类型有一定差异,但整合的位点和拷贝数都较少,且多呈串联或紧密连锁的整合;（     

人尿激酶原乳腺定位转基因小鼠的建立

应用大鼠β乳酪蛋白基因的上游调控序列和人尿激酶原ｃＤＮＡ构建成功了乳腺定位表达载体．用显微注射的手段导入到受精卵的雄前核,从注射的３００枚受精卵中,１４０枚被移植到９只假孕的受体小鼠．结果从获得的子一代小鼠中,经ＰＣＲ和Ｓｏｕｔｈｅｒｎｂｌｏｔ证实,有３只转基因阳性的小鼠．     

Identification of holocarboxylase synthetase chromatin binding sites in human mammary cell lines using the DNA adenine methyltransferase identification technology

Holocarboxylase synthetase (HCS) is a chromatin protein that is essential for mediating the covalent binding of biotin to histones. Biotinylation of histones plays crucial roles in the repression of genes and repeats in the human genome. We tested the feasibility of DNA adenine methyltransferase identification (DamID) technology to map HCS binding sites in human mammary cell lines. Full-length HCS was fused to DNA adenine methyltransferase (Dam) for subsequent transfection into breast cancer (MCF-7) and normal breast (MCF-10A) cells. HCS docking sites in chromatin were identified by using the unique adenine methylation sites established by Dam in the fusion construct; docking sites were unambiguously identified using methylation-sensitive digestion, cloning, and sequencing. In total, 15 novel HCS binding sites were identified in the two cell lines, and the following 4 of the 15 overlapped between MCF-7 and MCF-10A cells: inositol polyphosphate-5-phosphatase A, corticotropin hormone precursor, ribosome biogenesis regulatory protein, and leptin precursor. We conclude that DamID is a useful technology to map HCS binding sites in human chromatin and propose that the entire set of HCS binding sites could be mapped by combining DamID with microarray technology.